Author: Bella Hayes

New York, New York–(Newsfile Corp. – January 10, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ASP Isotopes Inc. (NASDAQ: ASPI) between October 30, 2024 and November 26, 2024, both dates inclusive (the “Class Period”), of the important February 3, 2025 lead plaintiff deadline. SO WHAT: If you purchased ASP Isotopes securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the ASP Isotopes class action, go to https://rosenlegal.com/submit-form/?case_id=32062…

Read More

Derek J. Maetzold, President and CEO of Castle Biosciences Inc . (NASDAQ:), has recently sold company shares amounting to $228,066. The transactions, which took place on January 6 and 7, 2025, involved multiple trades with prices ranging from $28.421 to $30.175 per share. The stock has since surged, showing a remarkable 20.7% gain in the past week, with InvestingPro data indicating the stock is currently trading in overbought territory. The sales were executed under a Rule 10b5-1 trading plan, a pre-arranged plan that allows company insiders to sell a predetermined number of shares at a predetermined time. This plan was…

Read More

Sean A. Power, the Chief Financial Officer of TG Therapeutics, Inc. (NASDAQ:), recently executed a series of stock sales amounting to $629,382, according to a recent SEC filing. The transactions, which took place on January 3 and January 6, involved the sale of 11,337 and 10,021 shares of common stock, respectively. The shares were sold at prices ranging from $28.534 to $30.294 per share. According to InvestingPro data, TGTX currently trades near $28, with analyst price targets ranging from $10 to $55, reflecting the stock’s notable volatility. These sales were conducted automatically to cover tax obligations related to the vesting…

Read More

Mark Casper, the Executive Vice President and Chief Legal Officer of Marvell (NASDAQ:) Technology, Inc. (NASDAQ:MRVL), recently sold 2,500 shares of the company’s common stock. The shares were sold at a weighted average price of $113, amounting to a total transaction value of $282,500. The transaction comes as Marvell, now valued at over $103 billion, trades near its 52-week high of $126.15, having delivered an impressive 99% return over the past year. This sale was executed under Casper’s 10b5-1 plan, which was adopted on January 19, 2024. Following the transaction, Casper retains ownership of 24,706 shares, which includes 169 shares…

Read More

BROOKFIELD, Conn.—Lee Kang Jyh, the Chief Executive Officer of Photronics Inc. (NASDAQ:), sold a significant portion of his holdings in the company earlier this month. According to a recent SEC filing, Mr. Lee sold a total of 17,500 shares of common stock over two transactions on January 2, 2025. The shares were sold at prices ranging from $24.00 to $24.20, amounting to a total transaction value of approximately $421,750. InvestingPro analysis shows the stock trading at an attractive P/E ratio of 11.6, with analysts setting a price target of $35. Following these sales, Mr. Lee’s direct ownership in Photronics stands…

Read More

New York, New York–(Newsfile Corp. – January 5, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Caribou Biosciences, Inc. (NASDAQ: CRBU) between July 14, 2023 and July 16, 2024, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than February 24, 2025. SO WHAT: If you purchased Caribou securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs…

Read More

December 2025 Anniversary Cruise to Mexican Riviera to Recreate First-Ever Sailing ; Legendary Music Group, The Temptations, to Join the Party   LOS ANGELES, Jan. 4, 2025 /PRNewswire/ — Princess Cruises, known around the world as “The Love Boat,” is celebrating six decades of delivering dream vacations and happiness to millions of cruisers with a special 14-day 60th Anniversary Mexican Riviera Voyage, departing from the Port of Los Angeles on December 6, 2025. On sale now, this milestone cruise onboard Royal Princess will include some of the same ports on the first-ever voyage that set sail on December 3, 1965,…

Read More

New York, New York–(Newsfile Corp. – January 4, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sun Communities, Inc. (NYSE: NYSE:) between February 28, 2019 and September 24, 2024, both dates inclusive (the “Class Period”), of the important February 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Sun Communities securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Sun Communities class action, go to https://rosenlegal.com/submit-form/?case_id=32347…

Read More

New York, New York–(Newsfile Corp. – January 3, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) pursuant and/or traceable to Kyverna’s initial public offering conducted on February 8, 2024 (the “IPO”), of the important February 7, 2025 lead plaintiff deadline. SO WHAT: If you purchased Kyverna common stock you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Kyverna class action, go to https://rosenlegal.com/submit-form/?case_id=32239 or call Phillip…

Read More